USPTO serial 90765843
LYBALVI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 20, 2026
- Examiner
- MITTLER,KEVIN A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LYBALVI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Alkermes Pharma Ireland Limited
Dublin 4, IE
Alkermes Pharma Ireland Limited
Dublin 4, IE
Alkermes Pharma Ireland Limited
Dublin 4, IE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Norm J. Rich
Norm J. Rich FOLEY & LARDNER LLPSIXTH FLOOR3000 K STREET, N.W.WASHINGTON, DC 20007Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Logistics management in the field of medication, namely, business services in the nature of supporting the coordination of medication delivery to avoid product delivery delays; providing business administration information to patients and health care providers about medication reimbursement options regarding reimbursement procedures; providing information about pharmaceutical services, namely, providing information about pharmacy authorization in the nature of prescription fulfillment and approval instructions for delivery of medication in the nature of accepting payment terms | ACTIVE | Feb 23, 2022 |
| 036 | Providing information about pharmaceutical coverage by patient health plans; providing insurance administration information to patients and health care providers about medication reimbursement options; insurance services being support services for patients and for health care providers on behalf of their patients, namely, providing health benefit verification services to determine coverage of medication treatment; financial administration of medication reimbursement programs being support services for patients and for health care providers on behalf of their patients, namely, coordinating medication reimbursement programs | ACTIVE | Feb 23, 2022 |
| 044 | Providing educational information in the field of medication treatment to health care providers and patients; providing educational information about the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals and pharmaceutical products for medical purposes | ACTIVE | Feb 23, 2022 |
| 045 | Support services for health care providers and their patients in the nature of providing case management services, namely, coordinating the procurement of medication in the nature of conducting benefits verification with payers to facilitate prescription fulfilment and coordinating with non-commercial pharmacy to facilitate prescription fulfilment for patients eligible for patient assistance program; providing case management services in the nature of support services for patients and for health care providers on behalf of their patients, namely, coordinating the procurement of medication in the nature of conducting benefits verification with payers to facilitate prescription fulfilment and coordinating with non-commercial pharmacy to facilitate prescription fulfilment for patients eligible for patient assistance program | ACTIVE | Feb 23, 2022 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Alkermes Pharma Ireland Limited
- Other trademarks owned by Alkermes Pharma Ireland Limited
- Other trademarks owned by Alkermes Pharma Ireland Limited
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named LYBALVI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 20, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 20, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 30, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Dec 30, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 27, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 26, 2023 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 26, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 25, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 19, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 19, 2023 | IUAF | USE AMENDMENT FILED | — |
| May 19, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 19, 2023 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Nov 29, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 17, 2022 | NEWN | NEW NOA TO ISSUE | — |
| Jul 28, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 26, 2022 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| May 31, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 31, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 11, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 26, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 26, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 26, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 26, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 26, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 15, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 29, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Mar 15, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 14, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 14, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 14, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 14, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 1, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 1, 2021 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 31, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 14, 2021 | NWAP | NEW APPLICATION ENTERED | — |